CO6640053A1 - Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients - Google Patents

Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients

Info

Publication number
CO6640053A1
CO6640053A1 CO11128862A CO11128862A CO6640053A1 CO 6640053 A1 CO6640053 A1 CO 6640053A1 CO 11128862 A CO11128862 A CO 11128862A CO 11128862 A CO11128862 A CO 11128862A CO 6640053 A1 CO6640053 A1 CO 6640053A1
Authority
CO
Colombia
Prior art keywords
allopathic
combination
homeopathic
metallicum
concentrations
Prior art date
Application number
CO11128862A
Other languages
Spanish (es)
Inventor
Lopez Carlos Eduardo Chacon
Original Assignee
Amd Hair S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amd Hair S A filed Critical Amd Hair S A
Priority to CO11128862A priority Critical patent/CO6640053A1/en
Publication of CO6640053A1 publication Critical patent/CO6640053A1/en

Links

Abstract

La presente invención pertence al campo de la tecnología farmacéutica y revela composiciones farmacéuticas líquidas y estables para tratar la alopecia y estimular la regeneración capilar, cuyo componente activo esta conformado por una concentración estable de concentraciones alopáticas, y diluciones homeopáticas de sustancias con actividad antialopécica y de regenarción capilar, en presencia un vehículo farmacéuticamente apropiado para su administración intradérmica.Las composiciones reveladas contienen, como agentes activos alopáticos en concentración determinada, una combinación simultánea de Biotina, D-Pantenol, Pentoxifilina, Extracto de Saw Palmetto y Minoxidil, y como agentes activos homeopáticos de dilución decimal (potencia D), una combinación también simultánea de Oligoelementos, cuyas tinturas madres tienen origen, o bien en el elemento puro, o bien en sales, de Silicio (Acidum silicum), Oro (Aurum Metallicum), Calcio (Calcium carbonicum), Cobalto (Cobaltum nitricum), Cobre (Cuprum metallicum), Hierro (Ferrum metallicum), Yodo (iodum), Cromo (Kalium bichroricum), Litio ( Lithium carbonicum), Magnesio (Magnesium chloratum), Manganeso (Manganum Sulphuricum), Cloro (Natrium chloratum), Fósforo (Phosporus) y azufre (Sulphur iodatum). La mencionada combinación de agentes alopáticos y homeopáticos es transpotada en un vehículo líquido isotónico farmacéuticamente aceptable, apto para la administración intradérmica de las formulaciones.The present invention belongs to the field of pharmaceutical technology and reveals liquid and stable pharmaceutical compositions for treating alopecia and stimulating capillary regeneration, whose active component is formed by a stable concentration of allopathic concentrations, and homeopathic dilutions of substances with antialopetic activity and capillary regeneration, in the presence of a pharmaceutically suitable vehicle for intradermal administration.The disclosed compositions contain, as allopathic active agents in determined concentration, a simultaneous combination of Biotin, D-Panthenol, Pentoxifylline, Saw Palmetto Extract and Minoxidil, and as active agents Homeopathic dilution decimal (power D), a simultaneous combination of trace elements, whose mother tinctures have origin, either in the pure element, or in salts, of Silicon (Acidum silicum), Gold (Aurum Metallicum), Calcium (Calcium carbonicum), Cobalt (Cob altum nitricum), Copper (Cuprum metallicum), Iron (Ferrum metallicum), Iodine (iodum), Chromium (Kalium bichroricum), Lithium (Lithium carbonicum), Magnesium (Magnesium chloratum), Manganese (Manganum Sulphuricum), Chlorine (Natrium chloratum) , Phosphorus (Phosporus) and Sulfur (Sulfur iodatum). The aforementioned combination of allopathic and homeopathic agents is transpoted in a pharmaceutically acceptable isotonic liquid vehicle, suitable for intradermal administration of the formulations.

CO11128862A 2011-09-30 2011-09-30 Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients CO6640053A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO11128862A CO6640053A1 (en) 2011-09-30 2011-09-30 Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO11128862A CO6640053A1 (en) 2011-09-30 2011-09-30 Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients

Publications (1)

Publication Number Publication Date
CO6640053A1 true CO6640053A1 (en) 2013-03-22

Family

ID=49117564

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11128862A CO6640053A1 (en) 2011-09-30 2011-09-30 Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients

Country Status (1)

Country Link
CO (1) CO6640053A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017005942A1 (en) * 2015-07-08 2017-01-12 Armesso Am España, S.L. Pharmaceutical composition that promotes capillary regeneration

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017005942A1 (en) * 2015-07-08 2017-01-12 Armesso Am España, S.L. Pharmaceutical composition that promotes capillary regeneration
EP3320909A4 (en) * 2015-07-08 2019-03-13 Armesso Am España, S.L. Pharmaceutical composition that promotes capillary regeneration

Similar Documents

Publication Publication Date Title
EA201591050A1 (en) IMIDAZOPIRIDINE CONNECTIONS
MX2016002368A (en) Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators.
CL2015001386A1 (en) Fertilizer composition
MX2021007580A (en) Fused bicyclic sgc stimulators.
EA201400976A1 (en) BENZODIOXANES IN COMBINATION WITH OTHER ACTIVE MEANS TO INHIBIT LEUKOTRIEN PRODUCTION
PE20151727A1 (en) 2-AZA-BICYCLE ACID [2.2.1] HEPTANE-3-CARBOXYL (BENZYL-CYAN-METHYL) -AMIDES SUBSTITUTED, CATEPSIN C INHIBITORS
EA201391623A1 (en) TRANSVERSE COMPOSITIONS IBUPROFENA AND METHODS OF THEIR APPLICATION
BR112018068734A2 (en) method for increasing the density of a well treatment brine
EA201390184A1 (en) ACTIVATING AMRK HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE
EA201391521A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING AND / OR MODULATING EFFECTOR T-CELLS PARTICIPATING IN THE INFLAMMATORY NEURODEGENERATIVE DISEASE
PE20142450A1 (en) DIFLUORO-HEXAHYDRO-CYCLOPENTAOXACINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXACINYLS AS BACE1 INHIBITORS
EA201591618A1 (en) SUBSTITUTED IMIDAZOPIRIDAZINES
AR094074A1 (en) COMPOSITIONS CONTAINING IONS OF STABLE METALS
BR112012024289A2 (en) "Method to Provide Safe and Effective Treatment of Erythema and Topical Gel Composition"
EA201170979A1 (en) CARBOXAMIDE COMPOUNDS AND METHODS OF THEIR APPLICATION
MX2016008077A (en) Fused heterocyclic compounds as ion channel modulators.
EA201600398A1 (en) TIENOPYRIMIDINES AS MKNK1 AND MKNK2 INHIBITORS
EA201490045A1 (en) DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA
CO6640053A1 (en) Pharmaceutical compositions for the treatment of alopecia, based on the combination of allopathic concentrations and homeopathic dilutions of active ingredients
BR112015029619A2 (en) 1,3-diaminocyclopentane carboxamide derivatives
EA201792085A1 (en) MIXED DISULPHIDE CONJUGATES OF THYENOPYRIDINE COMPOUNDS AND THEIR APPLICATION
EA201591704A1 (en) NEW SUSTAINABLE SALTS OF PENTADECEPEPTIDE, METHOD OF THEIR PRODUCTION, THEIR APPLICATION IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THERAPY
BR112013020195A2 (en) citrate free pharmaceutical compositions comprising anakinra
RU2012123788A (en) METHOD FOR TREATING ADVERSE EFFECTS AND ALLERGIC REACTIONS CAUSED BY RECEPTION OF THE MEDICINE USING TWO-COMPONENT MEDICINE
EA201270411A1 (en) SYNTHETIC HYBRID HYDROTALCITE-EUDRAGID URSODEOXYCHOLEIC ACID CONTAINING ITS PHARMACEUTICAL COMPOSITION AND METHOD FOR THEIR PRODUCTION